These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11751474)

  • 81. Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines.
    Sun C; Yamato T; Furukawa T; Ohnishi Y; Kijima H; Horii A
    Oncol Rep; 2001; 8(1):89-92. PubMed ID: 11115575
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Structural and functional analysis of SMAD4 gene promoter in malignant pancreatic and colorectal tissues: detection of two novel polymorphic nucleotide repeats.
    Nikolic A; Kojic S; Knezevic S; Krivokapic Z; Ristanovic M; Radojkovic D
    Cancer Epidemiol; 2011 Jun; 35(3):265-71. PubMed ID: 21036691
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Genetic abnormalities in pancreatic cancer.
    Moore PS; Beghelli S; Zamboni G; Scarpa A
    Mol Cancer; 2003 Jan; 2():7. PubMed ID: 12537585
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Microcystic tubulopapillary carcinoma of the pancreas: a new tumor entity?
    Esposito I; Bauer A; Hoheisel JD; Kleeff J; Friess H; Bergmann F; Rieker RJ; Otto HF; Klöppel G; Penzel R
    Virchows Arch; 2004 May; 444(5):447-53. PubMed ID: 15014986
    [TBL] [Abstract][Full Text] [Related]  

  • 85. SMAD4 germline mutations in juvenile polyposis coli.
    Wambach J; Barnard J
    J Pediatr Gastroenterol Nutr; 1999 May; 28(5):538-9. PubMed ID: 10328134
    [No Abstract]   [Full Text] [Related]  

  • 86. Molecular pathobiology of pancreatic adenocarcinoma.
    Mangray S; King TC
    Front Biosci; 1998 Nov; 3():D1148-60. PubMed ID: 9820739
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Genetic alterations in pancreatic carcinoma.
    Schneider G; Schmid RM
    Mol Cancer; 2003 Jan; 2():15. PubMed ID: 12605716
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo.
    Takagi Y; Kohmura H; Futamura M; Kida H; Tanemura H; Shimokawa K; Saji S
    Gastroenterology; 1996 Nov; 111(5):1369-72. PubMed ID: 8898652
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Two somatic biallelic lesions within and near SMAD4 in a human breast cancer cell line.
    Jakob J; Nagase S; Gazdar A; Chien M; Morozova I; Russo JJ; Nandula SV; Murty VV; Li CM; Tycko B; Parsons R
    Genes Chromosomes Cancer; 2005 Apr; 42(4):372-83. PubMed ID: 15645498
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cancer gets Mad: DPC4 and other TGFbeta pathway genes in human cancer.
    Moskaluk CA; Kern SE
    Biochim Biophys Acta; 1996 Dec; 1288(3):M31-3. PubMed ID: 9011179
    [No Abstract]   [Full Text] [Related]  

  • 91. Loss of heterozygosity of DPC4 tumor suppressor gene in human sporadic colon cancer.
    Had ija MP; Kapitanović S; Radosević S; Cacev T; Mirt M; Kovacević D; Cacev T; Hadzija M; Spaventi R; Pavelić K
    J Mol Med (Berl); 2001 Apr; 79(2-3):128-32. PubMed ID: 11357936
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Pancreatic carcinoma: a new suppressor gene has been found].
    Weismann H
    Dtsch Med Wochenschr; 1996 May; 121(21):A8-9. PubMed ID: 8646972
    [No Abstract]   [Full Text] [Related]  

  • 93. Collateral Lethality in Pancreatic Cancer.
    Cancer Discov; 2017 Apr; 7(4):342-343. PubMed ID: 28174172
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Genetic diagnosis of human pancreatic cancer].
    Horii A
    Nihon Shokakibyo Gakkai Zasshi; 2003 Mar; 100(3):292-7. PubMed ID: 12696169
    [No Abstract]   [Full Text] [Related]  

  • 95. DPC4 splice variants in neuroblastoma.
    Kageyama H; Seki N; Yamada S; Sakiyama S; Nakagawara A
    Cancer Lett; 1998 Jan; 122(1-2):187-93. PubMed ID: 9464509
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Generation of Smad4/Dpc4 conditional knockout mice.
    Yang X; Li C; Herrera PL; Deng CX
    Genesis; 2002 Feb; 32(2):80-1. PubMed ID: 11857783
    [No Abstract]   [Full Text] [Related]  

  • 97. A "catastrophic hypothesis" for pancreas cancer progression.
    Real FX
    Gastroenterology; 2003 Jun; 124(7):1958-64. PubMed ID: 12806629
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Correspondence re: S. Shimoyama et al., increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression. Clin. Cancer Res., 5: 1125-1130, 1999.
    Montero S; Lloveras B; Cortés-Funes H; Colomer R
    Clin Cancer Res; 1999 Nov; 5(11):3722-3. PubMed ID: 10589792
    [No Abstract]   [Full Text] [Related]  

  • 99. Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer.
    Mamot C; Mild G; Reuter J; Laffer U; Metzger U; Terracciano L; Boulay JL; Herrmann R; Rochlitz C
    Br J Cancer; 2003 Feb; 88(3):420-3. PubMed ID: 12569386
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Gene therapy and pancreatic cancer.
    Pearson AS; Bouvet M; Evans DB; Roth JA
    Front Biosci; 1998 Nov; 3():E230-7. PubMed ID: 9792901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.